Research
Adherence
Aggressive tobacco control reducing male smoking prevalence to 10% by 2030 prevents significant cardiovascular and noncardiovascular deaths in men, but fails to prevent cardiovascular deaths in women.
Aggressive national tobacco control policies targeting male smoking prevalence (down to 10% by 2030) can prevent millions of total deaths in men, though this specific intervention does not reduce cardiovascular mortality in women.
ModerateQualifiesMEDIUM confidence
Aggressively reducing active smoking in Chinese men to 20% prevalence in 2020 and 10% prevalence in 2030... would counteract adverse trends in other risk factors by preventing cardiovascular events and 2.9 to 5.7 million total deaths over 2 decades.
Why this rating
Based on simulation modeling of policy scenarios.
Source
Future Cardiovascular Disease in China
Andrew E. Moran et al. · Circulation Cardiovascular Quality and Outcomes · 2010
DOI 10.1161/circoutcomes.109.910711
narrative_reviewCited 434×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Aggressive population-level reduction of systolic blood pressure (SBP) by approximately 3.6–3.8 mm Hg is the most effective intervention to counteract the projected epidemic of cardiovascular disease in China, preventing 2.9 to 5.7 million deaths over 20 years.Moderate
- Population aging and growth alone will increase annual cardiovascular disease events by approximately 50% between 2010 and 2030 in China, even if all risk factors remain constant at 2000 levels.Moderate
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →